Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Menveo vaccine powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline UK Ltd) |
| BNF code | 1404000X0BIAAAC |
| Virtual Medicinal Product | Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials |
| Name | Menveo vaccine powder and solvent for solution for injection 0.5ml vials |
| Abbreviated name | Menveo vaccine inj 0.5ml vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Menveo vaccine powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.